MoneyWorks4Me

Sun Pharma’s arm acquires Uractiv Portfolio from Fiterman Pharma in Romania

27 May 2022 Evaluate

Sun Pharmaceutical Industries’ subsidiary -- S.C. Terapia S.A., Romania has acquired the Uractiv portfolio from Fiterman Pharma in Romania. The Uractiv portfolio comprises food supplements including minerals, vitamins and adjuvants; cosmetics and medical devices used for maintaining urinary tract health. 

Uractiv is the No. 1 brand in its category in Romania, trusted by consumers for more than 10 years. The portfolio including 12 SKUs has annualised revenues of approximately $8.7 million. The products cater to both adults and children. This acquisition is in line with company’s strategy to further expand its non-prescription product basket in Romania and neighbouring markets.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..